Boulder Hill Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,700
Closed -$194K 162
2023
Q2
$194K Buy
+17,700
New +$194K 0.37% 73